Insights

Washington – May 1, 2023: Aaron Cummings, former chief of staff to Republican U.S. Senator Charles E. Grassley of Iowa, the most senior member of the U.S. Senate, has joined Crowell & Moring to serve as co-chair of the firm’s bipartisan Government Affairs Group with partner Jim Flood, former Counsel to Sen. Majority Leader Charles E. Schumer (D-NY). 

Washington, D.C. – May 13, 2020: Kate Beale is joining Crowell & Moring and Crowell & Moring International LLC (CMI), bringing more than two decades of U.S. and international experience leading global health, international trade, investment, and economic policy in Congress, the Obama-Biden administration, foreign markets, and in C-suites across Global Fortune 500 companies.

Regardless of what happens in the U.S. elections on November 5, one theme is clear – protectionist policies in international trade are here to stay. To some extent, the key difference between the trade policies of a Harris administration and a second Trump Administration may be one of degree. Vice President Harris is expected to continue the more cautious, incremental approach to trade policy favored by the Biden Administration. A second Trump administration, on the other hand, is expected to pick up where it left off and aggressively use the trade tools at its disposal to try to reset and renegotiate trade relationships with many of the U.S.’s trading partners—particularly those countries with whom the U.S. has a trade deficit.

The U.S. Department of Commerce unveiled a groundbreaking analytic risk assessment tool to inform the U.S. government’s efforts in mitigating supply chain risks. Launched at the inaugural Supply Chain Summit hosted by the Department of Commerce and the Council on Foreign Relations on September 10, 2024, the SCALE Tool marks a significant milestone in the U.S. government’s broader commitment to strengthening the U.S. supply chain ecosystem. 

On July 9, 2024, the CHIPS Research and Development Office released a Notice of Intent (NOI) to announce a third CHIPS Act Notice of Funding Opportunity (NOFO), which will be the first focused on the CHIPS National Advanced Packaging Manufacturing Program.  The NOFO will provide up to $1.6 billion for research and development activities in five areas of semiconductor advanced packaging, including (1) equipment, tools, processes and process integration; (2) power delivery and thermal management; (3) connector technology like photonics and radio frequency; (4) the chiplets ecosystem; and (5) co-design/electronic design automation.  The NOFO is expected to include prototype development opportunities in exemplar applications including high-performance computing and low-power systems needed for artificial intelligence.  The NOI also provides information about eligibility expectations and other anticipated requirements for applications.

With the midterm elections (mostly) behind us, Congress is working through a list of must-pass items in the remaining days of the 117th Congress. Heading into the new divided Congress in 2023, with the narrowest Senate majority and House leadership not yet decided, we anticipate a move away from the Speaker-dominant House leadership model with small factions and individual members trying to exert influence over the agenda. We will discuss how razor-thin margins in both Congressional Chambers sets up a dynamic whereby President Biden and both parties in Congress will be motivated to find some common ground on legislation during the lame duck session and in the next two years. We will also provide insights into some key committees and issues that will be top priorities in the next Congress.

The Crowell Health Solutions, Crowell & Moring Government Affairs Group and Crowell & Moring International (CMI) team invite you to attend a webinar on what to expect in health care in 2023 on Capitol Hill, in the U.S. and abroad, now that U.S. Mid-Term Elections are over. In particular, this webinar will focus on key issues such as drug pricing, health care supply chains, data privacy regulation, general and reproductive rights issues, telehealth and concerns that matter to U.S. and global healthcare companies.